Treatment of hereditary cancers
About 10% of all children and adolescents with cancer are affected by a genetic disorder that is associated with an increased risk of cancer. A team of scientists and pediatric oncologists of the KiTZ has set itself the task to better investigate these so-called cancer predisposition syndromes (CPS) in order to derive new treatment methods for the affected children.
Because CPS are rare, the close exchange of information and experience with other centers is particularly important.
Cancer Predisposition Syndromes: The KiTZ is a "FIT" location in Heidelberg
The KiTZ represents the "FIT" network in Heidelberg and works in close cooperation with the Department of Pediatric Oncology of the Hannover Medical School (MHH), where the patients with cancer predisposition syndromes are registered.
The FIT (Facts, Investigation, Therapy) campaign is an initiative of the Hannover Medical School, which is concerned with the information and education on the topic of "pediatric cancer predisposition syndromes".
Together, we address cancer-epidemiological issues and keep samples from people with cancer predisposition syndromes to improve the long-term treatment and prognosis of these patients. The patient samples are stored at the Hannover Unified Biobank.
Additional information on "cancer predisposition syndromes: Facts - Investigation - Therapy" can be found on the joint websites of the KiTZ and the MHH.
Consultation „Cancer predisposition syndromes“
Responsible KiTZ physicians:
Prof. Dr. Stefan Pfister
Dr. med. Kristian Pajtler
Prof. Dr. Till Milde
Tel.: +49 6221 - 56 37082 (registration via the KiTZ Clinical Trial Unit)
- Oncology and hematology outpatient department of Heidelberg University hospital
- More information on cancer predisposition syndromes: Facts - Investigation - Therapy